Those confounded vitamins: What can we learn from the differences between observational versus randomised trial evidence?

Lancet

Volumn 363, Issue 9422, 2004, Pages 1724-1727

  Lawlor, Debbie A ^a   Smith, George Davey ^a   Kundu, Devi ^b   Bruckdorfer, K Richard ^b   Ebrahim, Shah ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; TOCOPHEROL; VITAMIN;

ANTIOXIDANT ACTIVITY; BEHAVIOR; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; EXERCISE; HUMAN; LEISURE; MULTIVARIATE ANALYSIS; OBSERVATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SOCIOECONOMICS; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 2442678802     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16260-0     Document Type: Note

References (21)

1. Khaw KT, Bingham S, Welch A, et al. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition. Lancet. 357:2001;657-663
2. Rimm EB, Stampfer MJ, Ascherio A, Giovannuci E, Colditz GA, Willet WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 328:1993;1450-1456
3. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary heart disease in women. N Engl J Med. 328:1993;1444-1449
4. The Alpha-Tocopherol Beta Carotene cancer prevention study group. The effect of vitamin E and Beta carotene on the incidence of lung cancer and other causes in male smokers. N Engl J Med. 330:1994;1029-1035
5. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 360:2002;23-33
6. Steinberg D, Witztum JL. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation. 105:2002;2107-2111
7. Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet. 357:2001;89-95
8. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 334:1996;1145-1149
9. Davey Smith G. Reflections on the limitations to epidemiology. J Clin Epidemiol. 54:2001;325-331
10. Gunnell D. Can adult anthropometry be used as a biomarker for prenatal and childhood exposures? Int J Epidemiol. 31:2002;390-394
11. Lawlor DA, Ebrahim S, Davey Smith G. The association between components of adult height and type II diabetes and insulin resistance: British Women's Heart and Health Study. Diabetologia. 45:2002;1097-1106
12. Davey Smith G, Hart C. Lifecourse socioeconomic and behavioural influences on cardiovascular disease mortality: the Collaborative Study. Am J Public Health. 92:2002;1295-1298
13. Greenland S. Basic methods for sensitivity analysis of biases. Int J Epidemiol. 25:1996;1107-1116
14. Phillips AN, Davey Smith G. The design of prospective epidemiological studies: more subjects or better measurements? J Clin Epidemiol. 46:1993;1203-1211
15. Nyyssonen K, Parviainen MT, Salonen R, Tuomilehto J, Salonen JT. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. BMJ. 314:1997;634-638
16. Holick CN, Michaud DS, Stolzenberg-Solomon R, et al. Dietary carotenoids, serum beta-carotene, and retinol and risk of lung cancer in the alpha-tocopherol, beta-carotene cohort study. Am J Epidemiol. 156:2002;536-547
17. Phillips AN, Davey Smith G. How independent are "Independent" effects? Relative risk estimation when correlated exposures are measured imprecisely. J Clin Epidemiol. 44:1991;1223-1231
18. Rothman KJ, Greenland S. Modern epidemiology. 2nd edn:1998;25 Lippincott Williams and Wilkins, Philadelphia
19. Weiss NS. Can the "specificity" of an association be rehabilitated as a basis for supporting a causal hypothesis? Epidemiology. 13:2002;6-8
20. Petitti DB, Perlman JA, Sidney S. Postmenopausal estrogen use and heart disease. N Engl J Med. 315:1986;131-132
21. Davey Smith G, Ebrahim S. Mendelian randomisation": can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 32:2003;1-22